Related Experiment Video
Updated: May 19, 2026
11:56
In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
Published on: September 28, 2017
Pro: Alzheimer's disease and circadian dysfunction: chicken or egg?
Tracy A Bedrosian1, Randy J Nelson1
1Department of Neuroscience, The Ohio State University Wexner Medical Center, 333 West 10th Avenue, Columbus, OH 43210, USA.
Alzheimer'S Research & Therapy
|August 14, 2012
Summary
Circadian rhythm disruption may worsen Alzheimer's disease (AD) pathology, not just be a symptom. Sleep and circadian factors influence amyloid-beta levels, suggesting a potential therapeutic target for AD.
Area of Science:
- Neuroscience
- Gerontology
- Pathology
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, characterized by cognitive decline.
- Circadian dysfunction is a common feature in AD patients.
- Traditionally viewed as a symptom, circadian disruption may actively contribute to AD pathology.
Purpose of the Study:
- To explore the reciprocal relationship between circadian rhythms, sleep, and Alzheimer's disease.
- To investigate how circadian dysregulation might exacerbate AD pathology.
- To examine the link between sleep-wake cycles, amyloid-beta deposition, and melatonin levels in AD.
Main Methods:
- Review of existing human and animal studies.
- Analysis of data on sleep deprivation effects on amyloid-beta (Aβ) in mice.
- Examination of the role of melatonin in AD and its connection to circadian rhythms.
Main Results:
- Evidence suggests a reciprocal link between sleep, circadian rhythms, and AD.
- Sleep deprivation increases amyloid-beta (Aβ) levels.
- Melatonin, a key circadian hormone, is dysregulated in AD and may have protective effects.
Conclusions:
- Circadian dysregulation may play a role in the pathogenesis of Alzheimer's disease.
- The sleep-wake cycle influences amyloid-beta deposition.
- Further research is needed to confirm the extent of the circadian system's contribution to AD.
Related Concept Videos
02:19Circadian Rhythms and Gene Regulation
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
02:19Circadian Rhythms and Gene Regulation
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...